Literature DB >> 10498885

Mouse models for colorectal cancer.

J Heyer1, K Yang, M Lipkin, W Edelmann, R Kucherlapati.   

Abstract

Colorectal cancer (CRC) is one of the most common cancers in the Western world. Much has been learned about colorectal cancer from human inherited syndromes, such as familial adenomatous polyposis (FAP) and hereditary non-polyposis colorectal cancer (HNPCC). Mouse models for CRC were generated by introducing mutations into the mouse genes, whose human counterparts were implicated in the onset and progression of CRC. Central among these are mice carrying mutations in the Adenomatous polyposis coli (Apc) gene. Although most of these Apc mutations share some common phenotypes as homozygous embryonic lethality and tumor predisposition, the severity of the tumor predisposition is variable. Mice with mutations in the mismatch repair genes, Msh2 and Mlh1, exhibit a mismatch repair defect and are predisposed to developing gastrointestinal cancer, lymphomas and tumors of other organ systems. Mice carrying a mutation in the Pms2 gene are predisposed to lymphomas and other tumors. Mice with a mutation in the Msh6 gene have a defect in base mismatch repair and show a tumor predisposition phenotype. Mice with mutations in Mlh1, Pms2 and Msh5 have defects in meiosis suggesting unique roles for these genes in gametogenesis.

Entities:  

Mesh:

Year:  1999        PMID: 10498885     DOI: 10.1038/sj.onc.1203036

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  41 in total

1.  p16(Ink4a) inhibits histologic progression and angiogenic signaling in min colon tumors.

Authors:  Steven L Gibson; Amelie Boquoi; Tina Chen; Norman E Sharpless; Colleen Brensinger; Greg H Enders
Journal:  Cancer Biol Ther       Date:  2005-12-09       Impact factor: 4.742

Review 2.  Polycyclic aromatic hydrocarbons and digestive tract cancers: a perspective.

Authors:  Deacqunita L Diggs; Ashley C Huderson; Kelly L Harris; Jeremy N Myers; Leah D Banks; Perumalla V Rekhadevi; Mohammad S Niaz; Aramandla Ramesh
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2011-10       Impact factor: 3.781

3.  High incidence of epithelial cancers in mice deficient for DNA polymerase delta proofreading.

Authors:  Robert E Goldsby; Laura E Hays; Xin Chen; Elise A Olmsted; William B Slayton; Gerry J Spangrude; Bradley D Preston
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-12       Impact factor: 11.205

Review 4.  Novel translational strategies in colorectal cancer research.

Authors:  Ignacio Gil-Bazo
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

Review 5.  Development of Preclinical Models to Understand and Treat Colorectal Cancer.

Authors:  Judith S Sebolt-Leopold
Journal:  Clin Colon Rectal Surg       Date:  2018-04-01

Review 6.  Mouse models for cancer stem cell research.

Authors:  Le Cheng; Anirudh V Ramesh; Andrea Flesken-Nikitin; Jinhyang Choi; Alexander Yu Nikitin
Journal:  Toxicol Pathol       Date:  2009-11-17       Impact factor: 1.902

7.  Dietary fat-influenced development of colon neoplasia in Apc Min mice exposed to benzo(a)pyrene.

Authors:  Deacqunita L Harris; Mary K Washington; Darryl B Hood; L Jackson Roberts; Aramandla Ramesh
Journal:  Toxicol Pathol       Date:  2009-12       Impact factor: 1.902

8.  Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses beta-catenin-dependent transcription.

Authors:  R Fukuyama; R Niculaita; K P Ng; E Obusez; J Sanchez; M Kalady; P P Aung; G Casey; N Sizemore
Journal:  Oncogene       Date:  2008-06-30       Impact factor: 9.867

9.  The Ets dominant repressor En/Erm enhances intestinal epithelial tumorigenesis in ApcMin mice.

Authors:  Paul Jedlicka; Xiaomei Sui; Arthur Gutierrez-Hartmann
Journal:  BMC Cancer       Date:  2009-06-22       Impact factor: 4.430

10.  Gene trapping identifies chloride channel 4 as a novel inducer of colon cancer cell migration, invasion and metastases.

Authors:  T Ishiguro; H Avila; S-Y Lin; T Nakamura; M Yamamoto; D D Boyd
Journal:  Br J Cancer       Date:  2010-01-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.